Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the nine research firms that are covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $70.22.
A number of brokerages have issued reports on ACHC. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and increased their price objective for the company from $45.00 to $75.00 in a report on Thursday, December 12th. Royal Bank of Canada restated an “outperform” rating and set a $64.00 price objective on shares of Acadia Healthcare in a research report on Friday, January 10th. Barclays cut their price target on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a report on Friday, November 22nd. KeyCorp upgraded Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 target price for the company in a research report on Tuesday, January 7th. Finally, TD Cowen reduced their price target on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a research report on Tuesday, January 7th.
Get Our Latest Report on Acadia Healthcare
Institutional Investors Weigh In On Acadia Healthcare
Acadia Healthcare Price Performance
NASDAQ ACHC opened at $43.78 on Tuesday. The company has a 50-day moving average price of $40.75 and a 200-day moving average price of $56.91. Acadia Healthcare has a 52 week low of $36.50 and a 52 week high of $87.77. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $4.07 billion, a P/E ratio of 14.35, a PEG ratio of 1.81 and a beta of 1.29.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The company had revenue of $815.60 million during the quarter, compared to analyst estimates of $819.42 million. During the same period in the prior year, the firm posted $0.91 EPS. The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. Equities research analysts anticipate that Acadia Healthcare will post 3.39 earnings per share for the current year.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Recommended Stories
- Five stocks we like better than Acadia Healthcare
- Most Volatile Stocks, What Investors Need to Know
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- 3 Fintech Stocks With Good 2021 Prospects
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.